Skip to main content

Market Overview

Benzinga's Top Upgrades, Downgrades For December 23, 2019

Share:

Upgrades

  • For 3M Co (NYSE: MMM), JP Morgan upgraded the stock from Underweight to Neutral. 3M earned $2.58 in the third quarter, compared to $2.58 in the year-ago quarter. The current market cap for 3M is at $97.6 billion. The stock has a 52-week-high of $219.75 and a 52-week-low of $150.58. 3M's stock last closed at $175.37 per share.
  • Sandler O'Neill upgraded the stock for Ready Capital Corp (NYSE: RC) from Hold to Buy. For the third quarter, Ready Capital had an EPS of $0.40, compared to year-ago quarter EPS of $0.48. The current market cap for Ready Capital is at $711.1 million. The stock has a 52-week-high of $16.90 and a 52-week-low of $13.44. Ready Capital's stock last closed at $15.48 per share.

 

Downgrades

  • H.C. Wainwright downgraded the stock for Stealth BioTherapeutics Corp (NASDAQ: MITO) from Buy to Neutral. Stealth BioTherapeutics earned ($0.04) in the third quarter. The current market cap for Stealth BioTherapeutics is at $406.6 million. The stock has a 52-week-high of $20.99 and a 52-week-low of $4.26. Stealth BioTherapeutics's stock last closed at $4.75 per share.
  • For Penske Automotive Group Inc (NYSE: PAG), Northcoast Research downgraded the stock from Buy to Neutral. For the third quarter, Penske Automotive Group had an EPS of $1.42, compared to year-ago quarter EPS of $1.40. The current market cap for Penske Automotive Group is at $3.9 billion. The stock has a 52-week-high of $53.81 and a 52-week-low of $38.53. Penske Automotive Group's stock last closed at $52.23 per share.
  • JP Morgan downgraded the stock for Rockwell Automation Inc (NYSE: ROK) from Neutral to Underweight. For the fourth quarter, Rockwell Automation had an EPS of $2.01, compared to year-ago quarter EPS of $2.11. The total market value of Rockwell Automation's outstanding shares is at $22.6 billion. The stock has a 52-week-high of $207.11 and a 52-week-low of $141.46. Rockwell Automation's stock last closed at $204.42 per share.
  • BTIG downgraded the stock for Valeritas Holdings Inc (NASDAQ: VLRX) from Buy to Neutral. For the third quarter, Valeritas Holdings had an EPS of ($1.91), compared to year-ago quarter EPS of ($0.49). The current market cap for Valeritas Holdings is at $12.2 million. The stock has a 52-week-high of $11.39 and a 52-week-low of $0.62. Valeritas Holdings's stock last closed at $0.65 per share.
  • For Valeritas Holdings Inc (NASDAQ: VLRX), Oppenheimer downgraded the stock from Outperform to Perform. For the third quarter, Valeritas Holdings had an EPS of ($1.91), compared to year-ago quarter EPS of ($0.49). The current market cap for Valeritas Holdings is at $12.2 million. The stock has a 52-week-high of $11.39 and a 52-week-low of $0.62. Valeritas Holdings's stock last closed at $0.65 per share.

 

Initiations

  • For Cracker Barrel Old Country Store Inc (NASDAQ: CBRL), CL King initiated coverage, by setting the current rating at Neutral. Cracker Barrel Old earned $1.90 in the first quarter, compared to $1.96 in the year-ago quarter. Cracker Barrel Old's market cap stands at $3.7 billion. The stock has a 52-week-high of $180.93 and a 52-week-low of $149.50. Cracker Barrel Old's stock last closed at $156.91 per share.
  • Itau BBA initiated coverage on GeoPark Ltd (NYSE: GPRK) with a Market Perform rating. The price target for GeoPark is set at $23.00. GeoPark earned $0.12 in the third quarter, compared to $0.33 in the year-ago quarter. GeoPark's market cap stands at $1.0 billion. The stock has a 52-week-high of $22.19 and a 52-week-low of $10.89. GeoPark's stock last closed at $21.69 per share.
  • With a rating of Outperform, Wedbush initiated coverage on IAC/InterActiveCorp (NASDAQ: IAC). The price target is set at $295.00 for IAC/InterActiveCorp. IAC/InterActiveCorp earned $1.35 in the third quarter, compared to $1.49 in the year-ago quarter. The total market value of IAC/InterActiveCorp's outstanding shares is at $19.2 billion. The stock has a 52-week-high of $268.72 and a 52-week-low of $161.39. IAC/InterActiveCorp's stock last closed at $245.84 per share.
  • With a rating of Neutral, Wedbush initiated coverage on Match Group Inc (NASDAQ: MTCH). The price target is set at $80.00 for Match Group. In the third quarter, Match Group showed an EPS of $0.51, compared to $0.39 from the year-ago quarter. The total market value of Match Group's outstanding shares is at $20.4 billion. The stock has a 52-week-high of $95.32 and a 52-week-low of $37.68. Match Group's stock last closed at $79.86 per share.
  • With a rating of Outperform, Oppenheimer initiated coverage on Soleno Therapeutics Inc (NASDAQ: SLNO). The price target is set at $10.00 for Soleno Therapeutics. For the third quarter, Soleno Therapeutics had an EPS of $0.03, compared to year-ago quarter EPS of ($0.11). Soleno Therapeutics's market cap stands at $68.3 million. The stock has a 52-week-high of $5.07 and a 52-week-low of $1.11. Soleno Therapeutics's stock last closed at $1.73 per share.
  • For Oxurion NV (OTC: TBGNF), Roth Capital initiated coverage, by setting the current rating at Buy. The current market cap for Oxurion is at $108.7 million. The stock has a 52-week-high of $5.20 and a 52-week-low of $2.82. Oxurion's stock last closed at $2.85 per share.
  • Cantor Fitzgerald initiated coverage on Taiwan Liposome Co Ltd (NASDAQ: TLC) with an Overweight rating. The price target for Taiwan Liposome Co is set at $11.00. In the third quarter, Taiwan Liposome Co earned ($0.09). The total market value of Taiwan Liposome Co's outstanding shares is at $195.2 million. The stock has a 52-week-high of $11.00 and a 52-week-low of $4.61. Taiwan Liposome Co's stock last closed at $5.70 per share.
  • With a rating of Outperform, Oppenheimer initiated coverage on X4 Pharmaceuticals Inc (NASDAQ: XFOR). The price target is set at $20.00 for X4 Pharmaceuticals. In the third quarter, X4 Pharmaceuticals showed an EPS of ($0.94), compared to ($0.76) from the year-ago quarter. The current market cap for X4 Pharmaceuticals is at $132.4 million. The stock has a 52-week-high of $23.93 and a 52-week-low of $9.36. X4 Pharmaceuticals's stock last closed at $10.40 per share.
 

Related Articles (CBRL + GPRK)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
FSRMorgan StanleyMaintains40.0
NATJefferiesMaintains2.8
MEDDA DavidsonMaintains302.0
VICRBWS FinancialMaintains120.0
PSXMizuhoMaintains96.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com